Abstract
There is a paucity of literature in EBV-Myopericarditis. Conventional treatment is based in Non-steroidal anti-inflammatory that aggravate myocardial injury. We present a Myopericarditis in a 22-year-old immunocompetent male by a stress-induced reactivation of EBV diagnosed by PCR in peripheral-blood. After three days of high fever, tonsillitis, enlarged submaxilar lymph nodes, and general myalgias, is admitted to the hospital with 1 h onset of severe retrosternal pleuritic pain, that evolved to a Myopericarditis with rapid increase of chest oppressive pain, in the precordial area, with diaphoresis, EKG abnormalities (diffuse ST-segment changes with elevation in AVL, V2–V6 derivations and PR depression) and within 8-h increased cardiac enzymes, Troponin T (0.893 ng/ml) Troponin I (18 ng/ml), CK-MB (82.02 ng/ml). Since evidence of myocardial injury increased, treatment was changed during the second severe chest pain, to Classic Homeopathy, treating the patient with Arnica montana (extract that contains Sesquiterpene lactones that inhibit NF-kappa B) for five weeks tapering the dose to then be followed by Thuja officinalis for 1 week. Concomitantly, Aspirin (1 g/d) for 4 weeks was added. After this integrative medicine treatment, there was a significant clinical improvement, fever subsided, C-Reactive-Protein decreased from 11.5 to 0.68 mg/dl, all the cardiac enzymes and EKG normalized rapidly. Additional results will be discussed. We present a novel therapeutic approach to a potentially fatal disease providing a starting point for groundbreaking research.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call